Cargando…
Current Melanoma Treatments: Where Do We Stand?
SIMPLE SUMMARY: In this manuscript, we discuss recent updates on melanoma-related clinical trial data. We explore diverse topics, including new therapeutic agents and novel combinations that are being tested in early-phase clinical trials. Furthermore, we review long-term efficacy and safety data fr...
Autores principales: | Moreira, Alvaro, Heinzerling, Lucie, Bhardwaj, Nina, Friedlander, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827568/ https://www.ncbi.nlm.nih.gov/pubmed/33435389 http://dx.doi.org/10.3390/cancers13020221 |
Ejemplares similares
-
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022) -
Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?
por: Paulbuddhe, Vivek, et al.
Publicado: (2021) -
Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013) -
Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
por: Dika, Emi, et al.
Publicado: (2021) -
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)